Back to search
FDAFDA · Food and drugs·Recall number Z-0783-2024

EliA GBM Wells, Material Number 14551401, for Phadia 250, 2500, and 5000. In vitro diagnostic

Published January 31, 2024 · Recall initiated: May 24, 2023

Summary

FDA records medical device Class II recall Z-0783-2024, published January 31, 2024 and initiated May 24, 2023. Recalling firm: Phadia Ab; Status: Ongoing; Reported quantity: 124,928 kits; Lot: UDI-DI: 07333066010670; All Lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Complaints that specific samples produced false positive EliA GBM results. A positive signal was present when these samples were tested for coating-solution reactivity using EliA wells without antigen.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Phadia Ab
Distributor
US Nationwide.
Lot
UDI-DI: 07333066010670; All Lots.
Risk classification
Class II
Area (FDA)
device
Country
Sweden

Related recalls

Questions about this recall

Was EliA GBM Wells, Material Number 14551401, for Phadia 250, 2500, and 5000. In vitro diagnostic recalled?

Yes. FDA published recall Z-0783-2024 on January 31, 2024. Reported hazard: Complaints that specific samples produced false positive EliA GBM results. A positive signal was present when these samples were tested for coating-solution reactivity using EliA wells without antigen.

What should I do if I have this product?

Voluntary: Firm initiated · Letter